000 01696 a2200469 4500
005 20250517001410.0
264 0 _c20151124
008 201511s 0 0 eng d
022 _a2326-6074
024 7 _a10.1158/2326-6066.CIR-14-0163
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBerger, Carolina
245 0 0 _aSafety of targeting ROR1 in primates with chimeric antigen receptor-modified T cells.
_h[electronic resource]
260 _bCancer immunology research
_cFeb 2015
300 _a206-16 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCell Movement
_ximmunology
650 0 4 _aCell Survival
_ximmunology
650 0 4 _aCytokines
_xblood
650 0 4 _aGenetic Engineering
_xmethods
650 0 4 _aGenetic Vectors
650 0 4 _aHumans
650 0 4 _aImmunotherapy, Adoptive
_xadverse effects
650 0 4 _aMacaca mulatta
650 0 4 _aModels, Animal
650 0 4 _aReceptor Tyrosine Kinase-like Orphan Receptors
_xmetabolism
650 0 4 _aReceptors, Antigen, T-Cell
_xgenetics
650 0 4 _aRetroviridae
_xgenetics
650 0 4 _aT-Lymphocytes
_ximmunology
650 0 4 _aTransduction, Genetic
700 1 _aSommermeyer, Daniel
700 1 _aHudecek, Michael
700 1 _aBerger, Michael
700 1 _aBalakrishnan, Ashwini
700 1 _aPaszkiewicz, Paulina J
700 1 _aKosasih, Paula L
700 1 _aRader, Christoph
700 1 _aRiddell, Stanley R
773 0 _tCancer immunology research
_gvol. 3
_gno. 2
_gp. 206-16
856 4 0 _uhttps://doi.org/10.1158/2326-6066.CIR-14-0163
_zAvailable from publisher's website
999 _c24315327
_d24315327